Trichomonas vaginalis Infection and Risk Factors among Infertile Women in Gaza, Palestine
Abstract
Keywords
Kaynakça
- 1. Garber GE. The laboratory diagnosis of Trichomonas vaginalis. Can J Infect Dis Med Microbiol 2005; 16: 35-38.
- 2. World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections –2008, WHO Library Cataloguing-in-Publication Data, 2012.
- 3. Workowski KA. Berman SM. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2006; 55: 1-94.
- 4. Francis SC, Kent CK, Klausner JD, et al. Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD clinic. Sex Transm Dis 2008; 35: 797-800. 5. Poole DN, McClelland RS. Global epidemiology of Trichomonas vaginalis. Sex Transm Infect 2014; 90: 75.
- 6. Sutcliffe S, Giovannucci E, Alderete JF, et al. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 939-45.
- 7. Gram IT, Macaluso M, Churchill J, et al. Trichomonas vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III. Cancer Causes Control 1992; 3: 231-236.
- 8. Van Der Pol B. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clin Infect Dis 2007; 44: 23-25.
- 9. Houso Y, Farraj MA, Ramlawi A, Essawi T. Detection of Trichomonas vaginalis in Vaginal Swab Clinical Samples from Palestinian Women by Culture. ISRN Microb 2011; 872358, 4 pages. http://dx.doi.org/10.5402/2011/872358.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Amal Youseff Al Maqadma
Bu kişi benim
Palestine
Adnan Ibrahim Al Hindi
*
Bu kişi benim
Palestine
Yayımlanma Tarihi
15 Aralık 2021
Gönderilme Tarihi
27 Aralık 2020
Kabul Tarihi
18 Kasım 2021
Yayımlandığı Sayı
Yıl 2021 Cilt: 11 Sayı: 04